Pathophysiology of Cardiovascular Complications in COVID-19

Autor: Vladimir Petrovic, Dina Radenkovic, Goran Radenkovic, Vukica Djordjevic, Maciej Banach

Publikováno v: Frontiers in Physiology, Vol 11 (2020)

Numerous recent studies have shown that patients with underlying cardiovascular disease (CVD) are at increased risk of more severe clinical course as well as mortality of COVID-19. Also, the available data suggests that COVID-19 is related to numerou

Externí odkaz: https://doaj.org/article/fad5a80a613c444481f77ea4b4231c1b

DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Autor: Katarina Tomovic, Mihajlo Gajić, Andrija Smelcerovic, Marko Anderluh, Dobrila Stankovic-Djordjevic, Vukica Djordjevic, Gordana Kocic

Publikováno v: Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in pharmacology, str. 1-4 : Ilustr., Vol. 11, 2020
COBISS-ID: 29551833
Frontiers in Pharmacology
Frontiers in pharmacology, vol. 11, 1185, 2020.

Since the outbreak of SARS-CoV-2 virus more than 12,500,000 cases have been reported worldwide. Patients suffering from diabetes and other comorbidities are particularly susceptible to severe forms of the COVID-19, which might result in chronic compl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b577296c596e1284d86d993cd69f28c
https://pubmed.ncbi.nlm.nih.gov/32848788